The SPAC said a virtual meeting of shareholders will be scheduled in early 2021. Nuvation Bio is focused on developing cancer treatments. Read more.
Related Posts
Priveterra Adjourns Aeon Merger Vote for the 6th Time
With previous delays, Priveterra cited the need for “additional time for the company to engage with its stockholders,” Priveterra said in earlier filings.
Highland Transcend Revises $250M Prospectus
The SPAC said it is focused on the travel & leisure, financial services, health & wellness, music & entertainment, media & mobile, and renewable energy/resource efficiency sectors.
Trident Acquisitions Seeks Approval for 3rd Deadline Extension
A proxy supplement outlining the request shows the SPAC changed the vote required to amend the trust agreement for extending the merger deadline from a majority of the outstanding shares of common stock sold in the IPO to a majority of the outstanding shares of common stock.
SPK Acquisition Files for $50M IPO
Based in Shanghai, SPK intends to target businesses in Asia focused on the TMT sectors.